Neuroprotection of medical IOP-lowering therapy

Cell and Tissue Research

Volumn 353, Issue 2, 2013, Pages 245-251

  Pfeiffer, Norbert ^a   Lamparter, Julia ^a   Gericke, Adrian ^a   Grus, Franz H ^a   Hoffmann, Esther M ^a   Wahl, Jochen ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Glaucoma; Intraocular pressure (IOP); IOP lowering medication; Neuroprotection

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAXOLOL; BIMATOPROST; BRAIN DERIVED NEUROTROPHIC FACTOR; BRIMONIDINE; CARBACHOL; CARBONATE DEHYDRATASE INHIBITOR; CARTEOLOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DICLOFENAMIDE; DIPIVEFRINE; DORZOLAMIDE; LATANOPROST; METIPRANOLOL; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; TAFLUPROST; TIMOLOL; TRAVOPROST; UNOPROSTONE;

APLASTIC ANEMIA; AQUEOUS HUMOR; ARGON LASER; ASTHMA; BRADYCARDIA; BRONCHOSPASM; DIURESIS; DOSE RESPONSE; EXCITOTOXICITY; EYE BLOOD FLOW; EYELASH; GLAUCOMA; HEART RATE; HUMAN; HYPEREMIA; HYPOKALEMIA; HYPOTENSION; INFLAMMATION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; IRIS DISEASE; LOW TENSION GLAUCOMA; MECHANICAL STRESS; MYOPIA; NEUROPROTECTION; NONHUMAN; OCULAR HYPEREMIA; OCULAR SURFACE DISEASE; OPEN ANGLE GLAUCOMA; OPTIC DISK; OPTIC NERVE DISEASE; OPTIC NERVE INJURY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUPIL CONSTRICTION; PUPIL DISEASE; RETINA BLOOD FLOW; REVIEW; SIDE EFFECT; TRABECULOPLASTY; UPREGULATION; UROLITHIASIS;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CYTOPROTECTION; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; NEURONS; NEUROPROTECTIVE AGENTS;

EID: 84880821622     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-013-1671-1     Document Type: Review

References (46)

1. Anderson DR, Hendrickson A (1974) Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest Ophthalmol 13:771-783
2. Bathija R (2000) Optic nerve blood flow in glaucoma. Clin Exp Optom 83:180-184
3. Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT (2005) The optic nerve head as a biomechanicl structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 24:39-73
4. Cheon EW, Park CH, Kang SS, Cho GJ, Yoo JM, Song JK, Choi WS (2003) Betaxolol attenuates retinal ischemia/reperfusion damage in the rat. Neuroreport 14:1913-1917
5. Gao H, Qiao X, Cantor LB, WuDunn D (2002) Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells. Arch Ophthalmol 120:797-803
6. Harris A, Chung HS, Ciulla TA, Kagemann L (1999) Progress flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog Retin Eye Res 18:669-687
7. Heijl A, Leske MC, Bengtsson B, Hymann L, Hussein M (2002) Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268-1279
8. Hiraoka M, Inoue K, Ninomiya T, Takada M (2003) Ischaemia in the Zinn-Haller circle and glaucomatous optic neuropathy in macaque monkeys. Trans Am Ophthalmol Soc 101:163-269
9. Hollander H, Makarov F, Stefani FH, Stone J (1995) Evidence of constriction of optic axons at the lamina cribrosa in the normotensive eye in humans and other mammals. Ophthalmic Res 27:296-309
10. Johnson DH, Bradley JMB, Acott TS (1990) The effect of dexamethasone on glycosaminoglycans of human trabecular meshwork in perfusion organ culture. Invest Ophthalmol Vis Sci 31:2568-2571
11. Kanamori A, Naka M, Fukuda M, Nakamuta M, Negi A (2009) Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo. Exp Eye Res 88:535-541
12. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO (2002) The Ocular Hypertension Treatment Study: a randomized trial determines that tropical ocular hypotensive medication delays or prevents the onset of privary open-angle glaucoma. Arch Ophthalmol 120:701-713
13. Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S (2011) A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol 151:671-681
14. Kuehn MH, Fingert JH, Kwon YH (2005) Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am 18:383-395
15. Martinez A, Sanchez-Salorio M (2009) A comparison of the long-term effects of dorzolamide 2% and brinzolamide 1%, each added to timolol 0.5%, on retrobulbar hemodynamics and intraocular pressure in open-angle glaucoma patients. J Ocul Pharmacol Ther 25:239-248
16. Miglior S, Pfeiffer N, Torri V, Zeyen T, Cunha-Vaz J, Adamsons I (2007) Predictive factors for open-angle-glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114:3-9
17. Minckler DS, Tso MO, Zimmerman LE (1976) A light microscopic, autoradiographic study of axoplasmic transport in the optic nerve head during ocular hypotonie, increased intraocular pressure, and papilledema. Am J Ophthalmol 82:741-757
18. Minckler DS, Bunt AH, Johanson GW (1977) Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci 16:426-441
19. Nakanishi Y, Nakamura M, Mukuno H, Kanamori A, Seigel GM, Negi A (2006) Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3 which is mediated by p44/p42 migenactivated protein kinase. Exp Eye Res 83:1108-1117
20. Ogidigben M, Chu TC, Potter DE (1994) Alpha-2-adrenoceptor mediated changes in aqueous dynamics: effect of perussis toxin. Exp Eye Res 58:729-736
21. Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M (2001) Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 21:1472-1479
22. Osborne NN, Cazervieille C, Carvalho AL, Larsen AK, DeSantis L (1997) In vivo and in vitro experiments show that betaxolol is retinal neuroprotective agent. Brain Res 751:113-123
23. Osborne NN, Ugarte M, Chao M, Chidlow G, Bae JH, Wood JP, Nash MS (1999) Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol 43(Suppl 1):S102-S128
24. Osborne NN, Wood JP, Chidlow G, Casson R, DeSantis L, Schmidt KG (2004) Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma. Brain Res Bull 62:525-428
25. Pedersen DB, Koch Jensen P, Cour M la, Kiilgaard JF, Eysteinsson T, Bang K, Wiencke AK, Stefánsson E (2005) Carbonic anhydrase inhibition increases retinal oxygen tension and dilates retinal vessels. Graefe Arch Clin Exp Ophthalmol 243:163-168
26. Pinar-Sueiro S, Urcola H, Rivas MA, Vecino E (2011) Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model. Clin Exp Ophthalomol 39:799-807
27. Priestley Smith J (1879) Glaucoma:its causes, symptoms, pathology, and treatment. Churchill, London
28. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262-267
29. Quigley HA, Addicks EM, Greenn WR, Maumence AE (1981) Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol 99:635-649
30. Reitsamer HA, Bogner B, Tockner B, Kiel JW (2009) Effects of dorzolamide on chorioidal blood flow, ciliary blood flow, and aqueous production in rabbits. Invest Ophthalmol Vis Sci 50:2301-2307
31. Rokicki W, Dorecka M, Romaniuk W (2007) Retinal ganglion cells death in glaucoma - mechanism and potential treatment. Part II. Klin Oczna 109:353-355
32. Saylor M, Mc Loon LK, Harrison AR, Lee MS (2009) Experimental and clinical evidence for brimonidine as an optic nerve and retinal neuroprotective agent: an evidence-based review. Arch Ophthalmol 12:402-406
33. Seki M, Tanaka T, Matsuda H, Togano T, Hashimoto K, Ueda J, Fukuchi T, Abe H (2005) Topically adminstered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model. Br J Ophthalmol 89:504-507
34. Shih GC, Calkins DJ (2012) Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action. Expert Rev Ophthalmol 7:161-175
35. Son JL, Soto I, Oglesby E, Lopez-Roca T, Pease ME, Quigley HA, Marsh-Armstrong N (2010) Glaucomatous optic nerve injury involves early astrocyte reactivity and late olig dendrocyte loss. Glia 58:780-789
36. Sugrue MF (2000) Pharmocological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog Retin Eye Res 19:87-112
37. Toris CB, Camras CB, Yablonski ME (1999) Acute versus chronic effects of brimonidine on qqueous humor dynamics in ocular hypertensive patients. Am J Ophthalmol 128:8-14
38. Torring MS, Holmgaard K, Hessellund A, Aalkjaer C, Bek T (2009) The vasodilating effect of actazolamide and dorzolamide involves mechanisms other than carbonic anhydrase inhibition. Invest Opthalmol Vis Sci 50:345-351
39. Wheeler LA, Lai R, Woldemussie E (1999) From the lab to the clilnic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury. Eur J Ophthalmol 9 (Suppl 1):S17-S21
40. Woldemussie E, Wijono M, Pow D (2007) Localization of alpha 2 receptors in ocular tissues. Vis Neurosci 24:745-756
41. Wood JP, DeSantis L, Chao HM, Osborne NN (2001) Topically applied betaxolol anttenuates ischaemia-induced effects to the rat retina and stimulates BDNF mRNA. Exp Eye Res 72:79-86
42. Wood JP, Schmidt KG, Melena J, Chidlow G, Allmeier H, Osborne NN (2003) The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol.Exp Eye Res 76:505-516
43. Yoles E, Wheeler LA, Schwartz M (1999) Alpha-2 adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci 40:65-73
44. Yoshida Y, Sugiyama T, Utsunomiya K, Oguta Y, Ikeda T (2010) A pilot study for the effects of donepezil therapy on cerebral and optic nerve head flow, visual field defect in normal-tension glaucoma. J Ocul Pharmacol Ther 26:187-192
45. Zhao DY, Cioffi GA (2000) Anterior optic nerve microvascular changes in human glaucomatous optic neuropathy. Eye (Lond) 14:445-449
46. Zheng J, Feng X, Hou L, Cui Y, Zhu L, Ma J, Xia Z, Zhou W, Chen H (2011) Latanoprost promotes neurote outgrowth in differentiated RGC-5 cells via the PI3K-Akt-mTOR signalling pathway. Cell Mol Neurobiol 31:597-604